In 2024, pharma and healthcare mutual funds performed well with returns of up to 44 per cent. Experts suggest investing at least 10-20 per cent of funds in these sector funds. There will be an advantage in the long term.
Experts suggest that those investing in mutual funds are likely to benefit in the long run if 10-20 per cent of the funds are allocated to the pharma and healthcare sector. This is because the demands for health care will definitely increase in the future. So there is a possibility of getting good returns. That is why it is being said that some amount should be allocated to healthcare sector funds.
Abhishek Jain, head of research at Arihant Capital, said the demand for healthcare will continue to grow in the long run due to population changes, lifestyle diseases and advances in medical technology. This sector is likely to provide solid returns. That’s why healthcare funds should have strategic allocations of 10-20 per cent of the total funds.
If you look at the performance of pharma and healthcare mutual funds, they have delivered good returns to investors with returns of nearly 44 per cent in 2024. A total of 13 mutual fund schemes were available in the sector and gave an average return of 37.20 per cent. HDFC Pharma and Healthcare Fund topped the list. Let’s take a look at the details of the remaining funds as well.
Performance of Pharma and Healthcare Funds in 2024
If you want to know the benefits of investing wisely in stocks, then join our course.
HDFC Pharma and Healthcare Fund – 43.77 per cent returns
ICICI Prudential Pharma Healthcare and Diagnostics Fund – 42.49 per cent returns
LIC MF Healthcare Fund – 40.85 per cent returns
UTI Healthcare Fund – 38.93 per cent returns
SBI Healthcare Opportunity Fund – 38.03 per cent returns
ITI Pharma and Healthcare Fund – 37.73 per cent returns
DSB Healthcare Fund – 37.69 per cent returns
Tata India Pharma and Healthcare Fund – 35.71 per cent returns
Mirai Asset Healthcare Fund – 35.66 per cent returns
Quant Healthcare Fund – 34.65 per cent returns
Kotak Healthcare Fund – 34.04 per cent returns
Aditya Birla SL Pharma and Healthcare Fund – 33.21 per cent returns
Nippon India Pharma Fund (G)- 30.90 per cent returns
Note: This article is for informational purposes only. Investing in mutual funds is associated with market risk. Based on past history, you cannot be sure that there will be returns in the future if you invest. It is advisable to take the advice and advice of experts before investing.
ABAC